C411H265N25S — CID 158147154
2-[9,10-bis(3,5-diphenylphenyl)-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-(9,10-dinaphthalen-2-ylanthracen-2-yl)-1,3-benzothiazole;2-[9,10-dinaphthalen-1-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-dinaphthalen-2-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[4-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]phenyl]-1-phenylbenzimidazole;1-phenyl-2-[6-(1-phenylbenzimidazol-2-yl)-9,10-bis(2-phenylphenyl)anthracen-2-yl]benzimidazole (PubChem CID 158147154) has the molecular formula C411H265N25S and a molecular weight of 5585.88 g/mol. Its IUPAC name is 2-[9,10-bis(3,5-diphenylphenyl)-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-(9,10-dinaphthalen-2-ylanthracen-2-yl)-1,3-benzothiazole;2-[9,10-dinaphthalen-1-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-dinaphthalen-2-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[4-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]phenyl]-1-phenylbenzimidazole;1-phenyl-2-[6-(1-phenylbenzimidazol-2-yl)-9,10-bis(2-phenylphenyl)anthracen-2-yl]benzimidazole.
| Compound Name | 2-[9,10-bis(3,5-diphenylphenyl)-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-(9,10-dinaphthalen-2-ylanthracen-2-yl)-1,3-benzothiazole;2-[9,10-dinaphthalen-1-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-dinaphthalen-2-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[4-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]phenyl]-1-phenylbenzimidazole;1-phenyl-2-[6-(1-phenylbenzimidazol-2-yl)-9,10-bis(2-phenylphenyl)anthracen-2-yl]benzimidazole |
|---|---|
| PubChem CID | 158147154 |
| Molecular Formula | C411H265N25S |
| Molecular Weight | 5585.88 g/mol |
| Exact Mass | 5581.12 |
| IUPAC Name | 2-[9,10-bis(3,5-diphenylphenyl)-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-(9,10-dinaphthalen-2-ylanthracen-2-yl)-1,3-benzothiazole;2-[9,10-dinaphthalen-1-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-dinaphthalen-2-yl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]-1-phenylbenzimidazole;2-[4-[9,10-diphenyl-6-(1-phenylbenzimidazol-2-yl)anthracen-2-yl]phenyl]-1-phenylbenzimidazole;1-phenyl-2-[6-(1-phenylbenzimidazol-2-yl)-9,10-bis(2-phenylphenyl)anthracen-2-yl]benzimidazole |
| SMILES | c1ccc(-c2c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3c(-c3ccccc3)c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc23)cc1.c1ccc(-c2c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3c(-c3ccccc3)c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc23)cc1.c1ccc(-c2cc(-c3ccccc3)cc(-c3c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4c(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc34)c2)cc1.c1ccc(-c2ccccc2-c2c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3c(-c3ccccc3-c3ccccc3)c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc23)cc1.c1ccc(-n2c(-c3ccc4c(-c5ccc6ccccc6c5)c5cc(-c6nc7ccccc7n6-c6ccccc6)ccc5c(-c5ccc6ccccc6c5)c4c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc4c(-c5cccc6ccccc56)c5cc(-c6nc7ccccc7n6-c6ccccc6)ccc5c(-c5cccc6ccccc56)c4c3)nc3ccccc32)cc1.c1ccc2cc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4cc(-c5nc6ccccc6s5)ccc34)ccc2c1 |
| InChI | InChI=1S/C76H50N4.C64H42N4.2C60H38N4.C58H38N4.C52H34N4.C41H25NS/c1-7-23-51(24-8-1)57-43-58(52-25-9-2-10-26-52)46-61(45-57)73-65-41-39-56(76-78-70-36-20-22-38-72(70)80(76)64-33-17-6-18-34-64)50-68(65)74(62-47-59(53-27-11-3-12-28-53)44-60(48-62)54-29-13-4-14-30-54)66-42-40-55(49-67(66)73)75-77-69-35-19-21-37-71(69)79(75)63-31-15-5-16-32-63;1-5-21-43(22-6-1)49-29-13-15-31-51(49)61-53-39-37-46(64-66-58-34-18-20-36-60(58)68(64)48-27-11-4-12-28-48)42-56(53)62(52-32-16-14-30-50(52)44-23-7-2-8-24-44)54-40-38-45(41-55(54)61)63-65-57-33-17-19-35-59(57)67(63)47-25-9-3-10-26-47;1-3-21-43(22-4-1)63-55-31-13-11-29-53(55)61-59(63)41-33-35-49-51(37-41)57(47-27-15-19-39-17-7-9-25-45(39)47)50-36-34-42(38-52(50)58(49)48-28-16-20-40-18-8-10-26-46(40)48)60-62-54-30-12-14-32-56(54)64(60)44-23-5-2-6-24-44;1-3-19-47(20-4-1)63-55-25-13-11-23-53(55)61-59(63)45-31-33-49-51(37-45)57(43-29-27-39-15-7-9-17-41(39)35-43)50-34-32-46(38-52(50)58(49)44-30-28-40-16-8-10-18-42(40)36-44)60-62-54-24-12-14-26-56(54)64(60)48-21-5-2-6-22-48;1-5-17-40(18-6-1)55-48-36-34-44(58-60-52-26-14-16-28-54(52)62(58)46-23-11-4-12-24-46)38-50(48)56(41-19-7-2-8-20-41)47-35-33-43(37-49(47)55)39-29-31-42(32-30-39)57-59-51-25-13-15-27-53(51)61(57)45-21-9-3-10-22-45;1-5-17-35(18-6-1)49-41-31-29-38(52-54-46-26-14-16-28-48(46)56(52)40-23-11-4-12-24-40)34-44(41)50(36-19-7-2-8-20-36)42-32-30-37(33-43(42)49)51-53-45-25-13-15-27-47(45)55(51)39-21-9-3-10-22-39;1-3-11-28-23-30(19-17-26(28)9-1)39-33-13-5-6-14-34(33)40(31-20-18-27-10-2-4-12-29(27)24-31)36-25-32(21-22-35(36)39)41-42-37-15-7-8-16-38(37)43-41/h1-50H;1-42H;2*1-38H;1-38H;1-34H;1-25H |
| InChIKey | FUQRITYUTFEICX-UHFFFAOYSA-N |
| XLogP | 108.22 |
| TPSA | 226.73 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 46 |
| Heavy Atoms | 437 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5585.88 |
| LogP ≤ 5 | 108.22 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 26 |